Trial intelligence / Profile preview

Oxycodone versus remifentanil for analgesia in mechanically ventilated ICU patients

ChiCTR2400091747Phase 4Recruiting

Sponsor
Affiliated Hospital of North Sichuan Medical College
Start
Nov 2024
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of oxycodone, remifentanil and propofol in pain (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Heart rate, Mean arterial pressure and 8 more. Started Nov 2024; status: recruiting.

02

Drugs

oxycodoneremifentanilpropofol
03

Conditions

pain

Beyond the preview

Go deeper on ChiCTR2400091747.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400091747.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call